뒤로
Therapeutic Solutions International Inc(TSOI) 가격
TSOI 주가 차트
TSOI 수입
Therapeutic Solutions International Inc
$0
0%
$0
종가: Jan 23, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Jan 23, 20:00:00 GMT-5
Earnings FAQ
TSOI의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Therapeutic Solutions International Inc TSOI의 지난 분기 매출 실적은 어땠나요?
Therapeutic Solutions International Inc의 매출 추정치는 얼마인가요?
Therapeutic Solutions International Inc의 수익 품질 점수는 얼마인가요?
Therapeutic Solutions International Inc는 언제 수익을 보고하나요?
Therapeutic Solutions International Inc의 예상 수익은 얼마인가요?
Therapeutic Solutions International Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0.0001
일일 범위
$0.0001 - $0.0001
52주 범위
$0.0001 - $0.0004
거래량
262.5K
평균 거래량
0
EPS(TTM)
-0.00
배당수익률
--
시가총액
$512.2K
TSOI란 무엇인가요?
Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The company is headquartered in Elk City, Idaho and currently employs 3 full-time employees. The company went IPO on 2008-06-09. The firm is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. The company has developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells. The company has obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE), TBI, and lung pathology.